va glp 1 criteria for use Perioperative management of patients taking glucagon-like peptide receptor agonists: Society Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement What is the VA's GLP-1

In the 34 included studies, 34 (100%) studies with 12993 (100%) participants reported a reduction in HbA1c, 32 (94%) studies with 12906 (99%) for weight loss, 27 (79%) studies with 11608 (89%) for the rate of adverse events, 29 (85%) studies with 12558 (96%) for the rate of serious adverse events, 30 (88%) studies with 12522 (96%) for the hypoglycemic events, 30 (88%) studies with 12638 (97%) for the rate of withdrawals due to adverse events

Provides antioxidant support to protect against free radical damage

10.3390/toxins13020106 42 JohanssonM

Patients who received GLP-1RAs were also associated with a significantly lower incidence of CVEs than individuals in the metformin and the second- or third-line glucose-lowering medications groups